GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (OTCPK:TWAPF) » Definitions » Shiller PE Ratio

TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Shiller PE Ratio : 11.02 (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is TOWA Pharmaceutical Co Shiller PE Ratio?

As of today (2024-06-06), TOWA Pharmaceutical Co's current share price is $24.35. TOWA Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was $2.21. TOWA Pharmaceutical Co's Shiller PE Ratio for today is 11.02.

The historical rank and industry rank for TOWA Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TWAPF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 8.44   Med: 13.45   Max: 22.66
Current: 13.56

During the past years, TOWA Pharmaceutical Co's highest Shiller PE Ratio was 22.66. The lowest was 8.44. And the median was 13.45.

TWAPF's Shiller PE Ratio is ranked better than
76.82% of 535 companies
in the Drug Manufacturers industry
Industry Median: 23.58 vs TWAPF: 13.56

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TOWA Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.644. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $2.21 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


TOWA Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for TOWA Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Shiller PE Ratio Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.97 13.83 13.82 9.65 -

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.65 8.64 13.56 11.03 -

Competitive Comparison of TOWA Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Shiller PE Ratio falls into.



TOWA Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TOWA Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=24.35/2.21
=11.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, TOWA Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.644/106.8000*106.8000
=0.644

Current CPI (Dec. 2023) = 106.8000.

TOWA Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.163 95.700 0.182
201406 0.247 98.000 0.269
201409 0.509 98.500 0.552
201412 0.795 97.900 0.867
201503 0.360 97.900 0.393
201506 0.355 98.400 0.385
201509 0.290 98.500 0.314
201512 0.354 98.100 0.385
201603 0.228 97.900 0.249
201606 -0.212 98.100 -0.231
201609 0.236 98.000 0.257
201612 0.765 98.400 0.830
201703 0.128 98.100 0.139
201706 0.340 98.500 0.369
201709 0.390 98.800 0.422
201712 0.511 99.400 0.549
201803 -0.168 99.200 -0.181
201806 0.609 99.200 0.656
201809 0.438 99.900 0.468
201812 0.717 99.700 0.768
201903 0.511 99.700 0.547
201906 0.655 99.800 0.701
201909 0.577 100.100 0.616
201912 0.672 100.500 0.714
202003 0.617 100.300 0.657
202006 0.583 99.900 0.623
202009 0.586 99.900 0.626
202012 0.587 99.300 0.631
202103 0.777 99.900 0.831
202106 0.958 99.500 1.028
202109 0.709 100.100 0.756
202112 1.005 100.100 1.072
202203 0.153 101.100 0.162
202206 0.204 101.800 0.214
202209 0.187 103.100 0.194
202212 -0.107 104.100 -0.110
202303 0.033 104.400 0.034
202306 0.683 105.200 0.693
202309 0.303 106.200 0.305
202312 0.644 106.800 0.644

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TOWA Pharmaceutical Co  (OTCPK:TWAPF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


TOWA Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Headlines

No Headlines